Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HCA Health Inc (HCA) vs HubSpot Inc (HUBS) Price & Performance

HCA Health IncTrade
HubSpot IncTrade

Price performance (Past 24H)

Key statistics

HCA Health Inc vs HubSpot Inc — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while HubSpot Inc trades at $228.3 (market cap $11.56B). The key difference: HCA Health Inc is far larger — about 8.3× HubSpot Inc's market cap, and HCA Health Inc pays a 0.7% dividend while HubSpot Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and HubSpot Inc for 78 Days on average.

HCAHUBS
Market Cap
$96.35B$11.56B
Volume
1,079,4531,891,287
Sector
HealthTechnology
52-Week High
$545.13$494.58
52-Week Low
$361.32$170.39
Typical Hold Time
76 Days78 Days
Enterprise Value
$146.88B$10.46B
Dividend Yield
0.7%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HCA Health Inc

HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with a net income margin of 8.77%. The stock is supported by a consensus analyst price target of $461.12 and a 63% buy rating. Recent news includes an upcoming Q3 2026 earnings call and completion of the College of Health Care Professions acquisition, highlighting growth initiatives amid ongoing legal investigations.

Outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and regulatory scrutiny. The stock offers value with a P/E of 14.92 and upside to the price target, though high debt levels and legal overhangs warrant caution for investors seeking stable healthcare exposure.

HubSpot Inc

HubSpot (HUBS) trades at $231.84, up 5.23% today, with a bullish technical trend and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, reaching $3.13B in 2025, though profitability metrics like net margin (4.26%) remain modest. The company's AI strategy and partnership with OpenAI are key recent developments, as highlighted in September 2026 news.

The outlook is positive given earnings beats and AI initiatives, but high valuation ratios (P/E 82.51) and competitive risks warrant caution. Upside to the $243.65 consensus price target appears achievable if margin expansion continues, though volatility near resistance at $236 could test gains.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HCA
1% Buy99% Sell
Avg holding period · 76 Days
HUBS
1% Buy99% Sell
Avg holding period · 78 Days

Top news

Latest headlines on both assets

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA →

About HubSpot Inc

HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.

Read more on HUBS →